An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis
Fogueri U, Charkoftaki G, Roda G, Tuey S, Ibrahim M, Persaud I, Wempe MF, Brown JM, Thurman JM, Anchordoquy TJ, Joy MS. An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis. Drug Delivery And Translational Research 2021, 12: 1445-1454. PMID: 34322850, DOI: 10.1007/s13346-021-01022-4.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosus nephritisKidney depositionImatinib mesylateMouse modelMRL/MpJ miceT-testStudent's t-testDose-toxicity relationshipLupus nephritisSystemic exposureRenal excretionMesangial locationsPharmacokinetic parametersPotential treatmentNaked drugPharmacokineticsNephritisNovel nanoformulationMiceMesylateFuture strategiesCurrent studyNanoformulationsEncouraging resultsKidney